We observed that fluoxetine treatment improved the cefaclor-induced reduction of serotonin and BDNF levels as well as the expression of pro-inflammatory cytokines, resulting in decrease anxiety- and depression-like behaviors in mice. Here, BDNF is linked to depressive disorder.